E76.03

Clinical Causes: It is caused by mutations in the IDUA gene, which provides instructions for making the enzyme alpha-L-iduronidase. The condition is inherited in an autosomal recessive pattern, meaning a person needs to inherit two copies of the defective gene, one from each parent, to develop the syndrome. Carriers, with only one copy of the mutated gene, typically do not show symptoms.

Key Symptoms: Hallmark features include mild to moderate skeletal abnormalities such as joint stiffness and limited mobility. Corneal clouding leading to vision problems. Hearing impairment due to ear infections or middle ear issues. Cardiac issues like valvular heart disease. Hepatosplenomegaly, which is enlarged liver and spleen. Distinct facial features including a coarsened face, broad nose, and enlarged tongue. Developmental delays are less prominent compared to more severe forms but may still be present.

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory testing. Key diagnostic steps include: - Measuring enzyme activity levels of alpha-L-iduronidase in blood or tissue samples. - Genetic testing to identify mutations in the IDUA gene. - Imaging studies such as X-rays to assess skeletal abnormalities. - Ophthalmologic examination to detect corneal clouding. - Cardiac assessments to evaluate heart function. These tests help confirm the presence of Scheie's syndrome and distinguish it from other types of mucopolysaccharidosis.

Treatment Protocols: While there is no cure for Scheie's syndrome, treatment aims to manage symptoms and improve quality of life. Approaches may include: - Enzyme replacement therapy (ERT) to supplement the deficient enzyme. - Symptomatic treatments such as physical therapy, orthopedic interventions, and hearing aids. - Regular monitoring by a multidisciplinary team including cardiologists, orthopedists, and ophthalmologists. - Supportive care, including educational assistance and psychosocial support. Early diagnosis and appropriate management are essential to address complications and enhance living outcomes.